Literature DB >> 19896382

Executive dysfunction and attention contribute to gait interference in 'off' state Parkinson's Disease.

Sue Lord1, Lynn Rochester, Vicki Hetherington, Liesl M Allcock, David Burn.   

Abstract

Motor and cognitive processes are required for successful 'real world' walking. We explored the specific contribution of motor function, executive function, and attention to functional gait performance in people with Parkinson's Disease (PD) when 'off' medication. Twenty-nine people with PD wearing an accelerometer were tested in their home whilst walking under four task conditions. Explanatory characteristics included age, motor function, executive function, sustained attention and divided attention. Repeated measures ANOVA compared gait speed under different task conditions. Multiple regression analysis explored the effect of characteristics on gait speed and gait interference (difference between dual and single task). Gait performance deteriorated under complex conditions (F=51.0, P<.001). Motor function and attention explained up to 65% variance in gait speed. Motor function, attention and executive function explained up to 66% variance in gait interference. Sustained attention explained up to 10% variance in gait speed; executive function explained up to 21% variance in gait interference and divided attention explained up to 22% variance in gait interference. Motor function, executive function and attention contribute to gait speed and gait interference in PD during a functional walking task whilst 'off' medication. When both executive function and attention are included as explanatory variables, attention discriminates gait performance more effectively. Whilst both contribute to functional gait, they are used selectively to optimise performance for different conditions and to meet complex task requirements. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19896382     DOI: 10.1016/j.gaitpost.2009.09.019

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  45 in total

1.  Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons.

Authors:  Cassandra Avila; Aaron Kucinski; Martin Sarter
Journal:  J Neurosci       Date:  2020-06-18       Impact factor: 6.167

Review 2.  Managing Gait, Balance, and Posture in Parkinson's Disease.

Authors:  Bettina Debû; Clecio De Oliveira Godeiro; Jarbas Correa Lino; Elena Moro
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-06       Impact factor: 5.081

3.  Dual task interference on postural sway, postural transitions and gait in people with Parkinson's disease and freezing of gait.

Authors:  Ana Claudia de Souza Fortaleza; Martina Mancini; Patty Carlson-Kuhta; Laurie A King; John G Nutt; Eliane Ferrari Chagas; Ismael Forte Freitas; Fay B Horak
Journal:  Gait Posture       Date:  2017-05-10       Impact factor: 2.840

Review 4.  The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?

Authors:  Orit Segev-Jacubovski; Talia Herman; Galit Yogev-Seligmann; Anat Mirelman; Nir Giladi; Jeffrey M Hausdorff
Journal:  Expert Rev Neurother       Date:  2011-07       Impact factor: 4.618

Review 5.  What can biomarkers tell us about cognition in Parkinson's disease?

Authors:  Brit Mollenhauer; Lynn Rochester; Alice Chen-Plotkin; David Brooks
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

6.  Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson's disease: does the levodopa overdose hypothesis extend to gait?

Authors:  Moria Dagan; Talia Herman; Hagar Bernad-Elazari; Eran Gazit; Inbal Maidan; Nir Giladi; Anat Mirelman; Brad Manor; Jeffrey M Hausdorff
Journal:  J Neurol       Date:  2020-09-09       Impact factor: 4.849

7.  Characterization of cognitive and motor performance during dual-tasking in healthy older adults and patients with Parkinson's disease.

Authors:  Lucia Bartmann Wild; Daiane Borba de Lima; Joana Bisol Balardin; Luana Rizzi; Bruno Lima Giacobbo; Henrique Bianchi Oliveira; Irani Iracema de Lima Argimon; Leonardo Alexandre Peyré-Tartaruga; Carlos R M Rieder; Elke Bromberg
Journal:  J Neurol       Date:  2012-09-29       Impact factor: 4.849

Review 8.  Molecular Imaging of the Cholinergic System in Parkinson's Disease.

Authors:  Nicolaas I Bohnen; Prabesh Kanel; Martijn L T M Müller
Journal:  Int Rev Neurobiol       Date:  2018-09-20       Impact factor: 3.230

Review 9.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

10.  Leakage of decision uncertainty into movement execution in Parkinson's disease?

Authors:  Peter Praamstra; Andrea F Loing; Floris P de Lange
Journal:  Exp Brain Res       Date:  2013-10-05       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.